Table 5.

Characteristics of the studies included in the systematic review [35].

First Author, Year	Country	Study Design	Study Period	Patients (n)	Procedure Details			Surgical Outcomes
					PM	Stent	Suture/Details (1)Inner Layer (2)Outer Layer	POPF (B-C)	DGE	PPH	Global Morbidity
Telford, 1984 [18]	USA	Case series	1975–1977	5	-	S0	Interrupted (1)4/0 silk (2)4/0 PGA	-	-	-	-
Shinchi, 2006 [19]	Japan	RCS	1996–2004	103	PM2	S1	Transfixing (1)2-0 silk (2)4-0 absorbable	2%	6%	-	23%
Fernández-Cruz, 2008 [17]	Spain	RCT	2005–2007	53	-	S1	Gastric partition (1)continuous	4%	4%	2%	23%
Takao, 2012 [32]	Japan	RCS	-	205	PM2	S1	Transfixing (1)2-0 silk (2)4-0 absorbable	2%	7%	-	19%
El Nakeeb 2014 [33]	Egypt	RCT	2011–2013	45	-	S0	Interrupted or continuous (1)3-0 silk (2)5/0 vicryl	15.5%	20%	8.9%	37.8%
Osman, 2014 [14]	Egypt	RCS	2009–2013	37	PM3	S1	Purse string (1)2/0 polypropylene + 3/0 polyglactin (2)4/0 polypropylene	2.7%	21.6%	2.7%	29.7%
Lu, 2017 [16]	China	RCS	2010–2014	143	PM2	S1	Running (1)4-0 polypropylene (2)5-0/6-0 PDS	0.7%	5.6%	-	28.7%
Bizzoca et al.	Italy	Case series	2012–2020	100	PM3	S2	Interrupted (1)3-0 PDS (2)4-0/5-0 PDS	8%	7%	8%	26%

PM pancreatic mobilization PM1 < 1 cm, PM2 1–2 cm, PM3 > 2 cm; S0 no stent, S1 internal pancreatic stent, S2 external pancreatic stent; POPF (B-C), post-operative pancreatic fistula; DGE, delayed gastric emptying, PPH, post-pancreatectomy hemorrhage; RCS, retrospective cohort study; RCT, randomized controlled trial, -, not reported; PGA, polyglicolic acid; PDS, polidioxanone.